https://www.biospace.com/crispr-focused-excision-biotherapeutics-announces-business-advisory-board-and-addition-of-interim-chief-business-officer
CRISPR-Focused Excision BioTherapeutics Announces Business Advisory Board and Addition of Interim...
Nov 3, 2020 - Excision BioTherapeutics Inc., a biotechnology company developing CRISPR-based therapeutics to cure viral infectious diseases, announced today the first...
business advisory boardexcision biotherapeutics
https://www.biospace.com/press-releases/excision-biotherapeutics-announces-publication-highlighting-ebt-107-for-the-treatment-of-chronic-hepatitis-b-in-biorxiv
Excision BioTherapeutics Announces Publication Highlighting EBT-107 for the Treatment of Chronic...
excision biotherapeutics
https://www.phillyvoice.com/hiv-cure-temple-research-crispr-gene-editing-dna/
Excision BioTherapeutics to launch clinical trial testing potential HIV cure | PhillyVoice
Feb 18, 2021 - Excision BioTherapeutics believes the gene-editing tool CRISPR may hold the key to curing HIV, the virus that turns to AIDS. The company, founded by two Temple...
clinical trial testingexcision biotherapeuticshiv curelaunch